1. Home
  2. MFA vs MGTX Comparison

MFA vs MGTX Comparison

Compare MFA & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MFA Financial Inc.

MFA

MFA Financial Inc.

N/A

Current Price

$5.78

Market Cap

957.0M

Sector

Real Estate

ML Signal

N/A

Logo MeiraGTx Holdings plc

MGTX

MeiraGTx Holdings plc

N/A

Current Price

$9.21

Market Cap

881.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MFA
MGTX
Founded
1997
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
957.0M
881.7M
IPO Year
1998
2018

Fundamental Metrics

Financial Performance
Metric
MFA
MGTX
Price
$5.78
$9.21
Analyst Decision
Buy
Buy
Analyst Count
7
8
Target Price
$12.58
★ $27.75
AVG Volume (30 Days)
★ 2.8M
607.2K
Earning Date
11-04-2026
11-12-2026
Dividend Yield
★ 25.90%
N/A
EPS Growth
★ 58.54
33.02
EPS
N/A
★ 0.68
Revenue
N/A
★ $81,391,000.00
Revenue This Year
N/A
$314.19
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$12.97
Revenue Growth
N/A
★ 144.57
52 Week Low
$5.55
$6.62
52 Week High
$10.43
$15.35

Technical Indicators

Market Signals
Indicator
MFA
MGTX
Relative Strength Index (RSI) 27.56 43.56
Support Level N/A $8.80
Resistance Level $6.87 $10.08
Average True Range (ATR) 0.24 0.53
MACD -0.05 0.08
Stochastic Oscillator 18.35 49.03

Price Performance

Historical Comparison
MFA
MGTX

About MFA MFA Financial Inc.

MFA Financial Inc is a specialty finance company that invests in and finances residential mortgage assets. Its principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. The company selectively invests in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return. The company's reportable segments include mortgage-related assets; and Lima One.

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.

Share on Social Networks: